Showing 1 - 10 results of 10 for search 'Bassam Francis Matti', query time: 0.03s Refine Results
  1. 1
    Evaluation of the Safety of Imatinib Mesylate in 200 Iraqi Patients with Chronic Myeloid Leukemia in the Chronic Phase: Single-Center Study

    Evaluation of the Safety of Imatinib Mesylate in 200 Iraqi Patients with Chronic Myeloid Leukemia in the Chronic Phase: Single-Center Study by Bassam Francis Matti, Alaadin Sahham Naji, Alaa Fadhil Alwan

    Published 2013-12-01
    Get full text
    Article
  2. 2
    Treatment Outcomes of Nilotinib as Second Line Therapy for Chronic Myeloid Leukemia Patients in Karbala Province of Iraq

    Treatment Outcomes of Nilotinib as Second Line Therapy for Chronic Myeloid Leukemia Patients in Karbala Province of Iraq by Ahmed Mjali, Mustafa Majeed Obaid, Bassam Francis Matti, Nareen Tawfeeq Abbas

    Published 2022-06-01
    Get full text
    Article
  3. 3
    The Role of Immune Check Point Gene Expression of Pd-1 and Tim-3 in Patients with Acute Myeloid Leukemia

    The Role of Immune Check Point Gene Expression of Pd-1 and Tim-3 in Patients with Acute Myeloid Leukemia by Sara Mohammed Oudah, Israa Hussein Hamzah, Bassam Francis Matti, Rashad Alkasir

    Published 2024-03-01
    Get full text
    Article
  4. 4
    The role of miRNA -150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients

    The role of miRNA -150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients by Kawthar Ali Radhi, Bassam Francis Matti, Israa Hussein Hamzah, Rashad Alkasir

    Published 2023-03-01
    Get full text
    Article
  5. 5
    Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers

    Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers by Nawar Maher, Samir Mouhssine, Bassam Francis Matti, Alaa Fadhil Alwan, Gianluca Gaidano

    Published 2023-06-01
    Get full text
    Article
  6. 6
    Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms

    Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms by Samir Mouhssine, Nawar Maher, Bassam Francis Matti, Alaa Fadhil Alwan, Gianluca Gaidano

    Published 2024-03-01
    Get full text
    Article
  7. 7
    Outcome of imatinib mesylate in women with child-bearing age diagnosed with chronic myeloid leukemia

    Outcome of imatinib mesylate in women with child-bearing age diagnosed with chronic myeloid leukemia by Alaa Fadhil Alwan, Manal Ali Abdulsahib, Fatma Abdulhamza Obed, Bassam Francis Matti

    Published 2021-01-01
    Get full text
    Article
  8. 8
    Treatment outcome of 100 chronic myeloid leukemia patients using nilotinib as the 2nd line therapy

    Treatment outcome of 100 chronic myeloid leukemia patients using nilotinib as the 2nd line therapy by Yaseen M Taher, Ali M Almothaffar, Bassam Francis Matti, Alaa Fadhil Alwan

    Published 2018-01-01
    Get full text
    Article
  9. 9
    Serum Calcium And Phosphateleveelsin Patients With Chronic Myeloid Leukemia Taking Different Dose of Tyrosine Kinase Inhibitors

    Serum Calcium And Phosphateleveelsin Patients With Chronic Myeloid Leukemia Taking Different Dose of Tyrosine Kinase Inhibitors by Bassam Francis Matti, Shahla'a Fadhil Sabir, Maysaa Ali Abdul Khaleq, Marwah Hasan Al kaabi

    Published 2018-03-01
    Get full text
    Article
  10. 10
    Do we need local guidelines for the diagnosis and management of immune thrombocytopenia in Iraq?

    Do we need local guidelines for the diagnosis and management of immune thrombocytopenia in Iraq? by Ahmed Mjali, Bassam Francis Matti, Nareen Tawfeeq Abbas, Hassan Ali Abood Nassrullah, Alaadin Sahham Naji, Alaa Fadhil Alwan, Waseem Fadhil Al-Tameemi, Haider Hasan Jaleel Al-Shammari, Tareq Abdullah Saleh, Mohammed Kamil Al Qayyim, Amer Shareef Mohammed

    Published 2023-01-01
    Get full text
    Article

Search Tools: